{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-001567","form_type":"8-K","ticker":"CLDI","cik":"0001855485","company_name":"Calidi Biotherapeutics, Inc.","filed_at":"2025-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.334243+00:00","generated_at":"2026-05-28T05:38:21.345610+00:00","sec_items":["1.01","3.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Calidi Biotherapeutics prices $4.25M public offering of 5M shares at $0.85/share","bullets":["Priced public offering of 5,000,000 shares at $0.85 per share for gross proceeds of $4.25 million.","Ladenburg Thalmann acting as exclusive placement agent; fees include 8% cash fee plus 1% management fee.","Placement agent warrants issued to purchase 250,000 shares at $1.0625 per share (125% of offering price).","Lock-up agreements: company 15 days, directors/officers 90 days from closing; agent may waive.","Net proceeds to be used for working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-001567","json":"https://secwatch.observer/filing/0001493152-25-001567.json","markdown":"https://secwatch.observer/filing/0001493152-25-001567.md","text":"https://secwatch.observer/filing/0001493152-25-001567.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855485/000149315225001567/0001493152-25-001567-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855485/000149315225001567/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T05:38:21.345610+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}